Stay updated on Pembro/Carbo/Taxol in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembro/Carbo/Taxol in Endometrial Cancer Clinical Trial page.

Latest updates to the Pembro/Carbo/Taxol in Endometrial Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange Detected- Added a consolidated Locations section listing the study sites by state (Arizona, Illinois, Indiana, Iowa, Minnesota) and updated the page revision to v3.3.3. Removed the separate state-location entries and the HHS Vulnerability Disclosure link.SummaryDifference0.6%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page now shows Revision: v3.3.2, replacing the previous Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check37 days agoChange DetectedRevision: v3.3.1 added; v3.2.0 removed, updating the study documents. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check45 days agoChange DetectedThe government funding lapse notice banner was removed from the page. The study details, interventions, locations, and eligibility criteria remain unchanged.SummaryDifference0.3%

- Check59 days agoChange DetectedNo significant changes detected between the old and new screenshots; the page content remains the same.SummaryDifference0.4%

- Check87 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference3%

Stay in the know with updates to Pembro/Carbo/Taxol in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembro/Carbo/Taxol in Endometrial Cancer Clinical Trial page.